Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > News > pSivida Provides Update on BrachySil(TM) Liver Program

May 25th, 2006

pSivida Provides Update on BrachySil(TM) Liver Program

Global bio-nanotech company pSivida Limited (NASDAQ:PSDV)(ASX:PSD)(Xetra:PSI) today announced that the scope of the BrachySil(TM) phase IIb clinical trial for inoperable primary liver cancer has expanded to encompass a roll-out to further clinical centers in new Asian territories. In addition to the five centers currently active in Singapore, and centers in Vietnam and Malaysia, new centers are being negotiated in the Philippines and Taiwan.


Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press


Tiny gold particles could be the key to developing a treatment for pancreatic cancer October 19th, 2016

Highly conductive and pure gold nanostructures grown by electron beam induced deposition October 17th, 2016

2D-nanocellulose: piezoelectric driven by a hydrogen bonds pattern October 15th, 2016

Particle Works offers bespoke microencapsulation for drug development October 13th, 2016


Exploding smartphones: What's the silent danger lurking in our rechargeable devices? New research identifies toxic emissions released by lithium-ion batteries October 21st, 2016

Move over, solar: The next big renewable energy source could be at our feet October 20th, 2016

Smashing metallic cubes toughens them up: Rice University scientists fire micro-cubes at target to change their nanoscale structures October 20th, 2016

Self-healable battery Lithium ion battery for electronic textiles grows back together after breaking October 20th, 2016

The latest news from around the world, FREE

  Premium Products
Only the news you want to read!
 Learn More
University Technology Transfer & Patents
 Learn More
Full-service, expert consulting
 Learn More

Nanotechnology Now Featured Books


The Hunger Project